RecruitingInterventionalPhase 4Updated May 29, 2026
A Study to Evaluate Sampling Methods for Subgingival Plaque | NCT02841839 | Trialant
CompletedInterventionalNot ApplicableUpdated Nov 15, 2023
A Study to Evaluate Sampling Methods for Subgingival Plaque
A Pilot Study to Evaluate Sampling Methods for Subgingival Plaque
ClinicalTrials.gov ID
NCT02841839
Lead Sponsor
Procter and GambleINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
20Actual
Last Update Posted
Nov 15, 2023Actual
Start Date
Jun 2016
Primary Completion Date
Jun 2016Actual
Completion Date
Jun 2016Actual
Official Title
A Pilot Study to Evaluate Sampling Methods for Subgingival Plaque
Brief Summary
To identify a sampling method for collecting subgingival plaque
Subgingival Plaque
Stannous Fluoride
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
Provide written informed consent to participate in the study;
Be 18 years of age or older;
Agree not to participate in any other oral/dental product studies during the course of this study;
Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed;
Agree to use the acclimation toothpaste together with their regular brush and refrain from any other oral care products (including floss and mouth rinse) between the Screening and Baseline Visit;
Agree to use the treatment products and refrain from any form of non-specified oral hygiene during the treatment periods (after the Baseline Visit), including but not limited to the use of products such as floss, mouth rinse, or whitening products;
Agree to return for all scheduled visits and follow study procedures;
Must have at least 16 natural teeth;
Be in good general health, as determined by the Investigator/designee based on a review of the health history/update for participation in the study;
Agree to refrain from all oral hygiene for at least 12 hours prior to each visit;
Agree to refrain from eating, chewing gum, drinking and using tobacco for 4 hours prior to each visit;
Have 10-20 bleeding sites; and
Have minimum 6 sampling sites with bleeding and pocket depth ≥2mm but not deeper than 4mm.
Exclusion Criteria:
Have had a dental prophylaxis within 2 weeks of plaque sampling visits;
Have taken antibiotics or used anti-gingivitis / anti-bacterial oral care products such as chlorhexidine or Listerine within 2 weeks of plaque sampling visits;
Have rampant caries, open or untreated caries, or advanced periodontitis requiring prompt treatment;
Taking allergy medication or any other medication that can affect salivary flow such as an antihistamine;
Need an antibiotic prophylaxis prior to dental visits;
A history of hypersensitivity to oral care products containing hydrogen peroxide or stannous fluoride;
A history of hypersensitivity to products containing sodium lauryl sulfate (SLS);
Are pregnant (Self-reported) or lactating; or
Have any condition or disease, as determined by the Investigator/Designee based on a review of the medical history, which could be expected to interfere with examination procedures or with the subject's safe completion of the study.